Semi-Annual Statement Of Income And Retained Earnings

TAIKO PHARMACEUTICAL CO., LTD. - Filing #7344643

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
-1,005,000,000 JPY
-1,192,000,000 JPY
1,212,000,000 JPY
-996,000,000 JPY
-1,039,000,000 JPY
-28,000,000 JPY
-8,000,000 JPY
-1,926,000,000 JPY
-3,079,000,000 JPY
-44,000,000 JPY
-1,152,000,000 JPY
-2,179,000,000 JPY
297,000,000 JPY
-2,955,000,000 JPY
Non-operating income
Non-operating income
82,000,000 JPY
66,000,000 JPY
109,000,000 JPY
91,000,000 JPY
Non-operating expenses
Non-operating expenses
325,000,000 JPY
358,000,000 JPY
383,000,000 JPY
410,000,000 JPY
Ordinary profit (loss)
-1,248,000,000 JPY
-1,331,000,000 JPY
-3,352,000,000 JPY
-3,274,000,000 JPY
Extraordinary income
Extraordinary income
298,000,000 JPY
298,000,000 JPY
JPY
JPY
Extraordinary losses
Extraordinary losses
2,613,000,000 JPY
2,657,000,000 JPY
1,516,000,000 JPY
1,673,000,000 JPY
Profit (loss) before income taxes
-3,563,000,000 JPY
-3,689,000,000 JPY
-4,869,000,000 JPY
-4,948,000,000 JPY
Income taxes - current
23,000,000 JPY
8,000,000 JPY
6,000,000 JPY
7,000,000 JPY
Income taxes - deferred
24,000,000 JPY
25,000,000 JPY
18,000,000 JPY
-1,000,000 JPY
Profit (loss)
-3,611,000,000 JPY
-3,724,000,000 JPY
-3,724,000,000 JPY
-3,724,000,000 JPY
-3,724,000,000 JPY
-4,895,000,000 JPY
-4,954,000,000 JPY
-4,954,000,000 JPY
-4,954,000,000 JPY
-4,954,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.